Cipla bse

We developed our XenoMouse technology, a technology using genetically modified mice to generate fully human antibodies. We also own a technology that enables the rapid identification of antibodies with desired function and characteristics, referred to as SLAM technology. thanks!? ranbaxy nexium exclusivity.

In our XenoMax technology, we use SLAM technology to select and isolate antibodies with particular function and characteristics from antibody-producing cells generated by XenoMouse animals.

We believe XenoMax technology enhances our capabilities in product development cipla bse and flexibility in manufacturing. We buy viagra 50 mg intend to use our technologies to build a large and diversified product portfolio that we expect to develop and commercialize through licensing arrangements with pharmaceutical companies and others, through joint development and through internal product development programs. A lot of Jewish faces in this film Is this some kind of private production? Or there's a certain reason as for why? what so ever provestra uk review. We have entered into a variety of contractual arrangements with multiple pharmaceutical, biotechnology and genomics companies involving our XenoMouse technology. Two of our customers, Pfizer and Amgen, have initiated clinical trials with order super force fully human antibodies generated from XenoMouse animals.

In addition, as of March 31, 2002, we had four proprietary antibody product candidates in clinical trials, one of which we had agreed to co-develop and commercialize with Immunex Corporation and one of which we had agreed to co-develop and commercialize with SangStat Medical Corporation.